Dharti Proteins Limited (BOM:531171)
85.38
+4.06 (4.99%)
At close: Oct 21, 2026
Dharti Proteins Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '15 Mar 31, 2015 | Mar '14 Mar 31, 2014 |
| 28.51 | - | - | - | - | - | |
Revenue Growth | - | - | - | - | - | - |
Cost of Revenue | 14.09 | - | - | - | - | - |
Gross Profit | 14.42 | - | - | - | - | - |
Selling, General & Admin | 0.6 | 0.06 | 0.03 | 0.21 | 0.19 | 0.34 |
Other Operating Expenses | 3.6 | 1.7 | 0.72 | - | 0.09 | - |
Operating Expenses | 4.18 | 1.76 | 0.79 | 0.25 | 0.29 | 0.34 |
Operating Income | 10.24 | -1.76 | -0.79 | -0.25 | -0.29 | -0.34 |
Interest Expense | - | - | -0 | -1.65 | - | -0 |
Interest & Investment Income | 0.3 | 0.3 | 0.72 | - | 0 | 0.01 |
Other Non Operating Income (Expenses) | 31.21 | - | - | - | -0.36 | -0.28 |
EBT Excluding Unusual Items | 41.74 | -1.46 | -0.07 | -1.9 | -0.65 | -0.61 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -6.61 |
Other Unusual Items | -7 | -7 | - | - | -0.01 | - |
Pretax Income | 34.74 | -8.47 | -0.07 | -1.9 | -0.66 | -7.22 |
Income Tax Expense | 10.41 | - | - | - | 0.11 | -0.06 |
Net Income | 24.33 | -8.47 | -0.07 | -1.9 | -0.77 | -7.16 |
Preferred Dividends & Other Adjustments | - | - | - | 0.89 | - | - |
Net Income to Common | 24.33 | -8.47 | -0.07 | -2.79 | -0.77 | -7.16 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Change | -96.31% | 1899.68% | -44.18% | 67.45% | 7.55% | -9.42% |
EPS (Basic) | 32.98 | -16.93 | -2.68 | -62.26 | -28.77 | -287.72 |
EPS (Diluted) | 32.98 | -16.93 | -4.11 | -62.26 | -28.77 | -287.72 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '15 Mar 31, 2015 | Mar '14 Mar 31, 2014 |
Gross Margin | 50.58% | - | - | - | - | - |
Operating Margin | 35.91% | - | - | - | - | - |
Profit Margin | 85.34% | - | - | - | - | - |
EBITDA | - | -1.73 | -0.75 | -0.21 | -0.28 | -0.34 |
D&A For EBITDA | - | 0.04 | 0.04 | 0.04 | 0.01 | 0 |
EBIT | 10.24 | -1.76 | -0.79 | -0.25 | -0.29 | -0.34 |
EBIT Margin | 35.91% | - | - | - | - | - |
Effective Tax Rate | 29.97% | - | - | - | - | - |
Revenue as Reported | 60.02 | 0.3 | 0.72 | - | 0 | 0.01 |
Advertising Expenses | - | 0.02 | 0.03 | - | - | - |